These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12543532)

  • 1. Health economic evaluation in Japan: a case study of one aspect of health technology assessment.
    Oliver A
    Health Policy; 2003 Feb; 63(2):197-204. PubMed ID: 12543532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health economic evaluation in Greece.
    Rovithis D
    Int J Technol Assess Health Care; 2006; 22(3):388-95. PubMed ID: 16984068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System.
    Hasegawa M; Komoto S; Shiroiwa T; Fukuda T
    Value Health; 2020 Jan; 23(1):43-51. PubMed ID: 31952673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of costs for health economic evaluation.
    Riewpaiboon A
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S17-26. PubMed ID: 24964695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.
    Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1593-600. PubMed ID: 8047916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology.
    Davies L; Coyle D; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1601-7. PubMed ID: 8047917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution and new perspectives of health care financing in developing countries].
    Audibert M; Mathonnat J; de Roodenbeke E
    Sante; 2003; 13(4):209-14. PubMed ID: 15047437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation in support of national health policy: the case of The Netherlands.
    Elsinga E; Rutten FF
    Soc Sci Med; 1997 Aug; 45(4):605-20. PubMed ID: 9226785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National health policies: sub-Saharan African case studies (1980-1990).
    Dugbatey K
    Soc Sci Med; 1999 Jul; 49(2):223-39. PubMed ID: 10414831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Researcher-driven versus policy-driven economic appraisal of health technologies: the case of France.
    Moatti JP; Chanut C; Benech JM
    Soc Sci Med; 1994 Jun; 38(12):1625-33. PubMed ID: 8047920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey.
    Tordrup D; Angelis A; Kanavos P
    Appl Health Econ Health Policy; 2013 Dec; 11(6):639-52. PubMed ID: 24129648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A changing medical and economic world: complex diseases and interest in economic evaluation of health technologies].
    Hiligsmann M; Reginster JY
    Rev Med Liege; 2012; 67(5-6):258-62. PubMed ID: 22891476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic appraisal in the British National Health Service: implications of recent developments.
    Henshall C; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1615-23. PubMed ID: 8047919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What should the government do regarding health policy-making to develop community health care in Shanghai?
    Yu Y; Sun X; Zhuang Y; Dong X; Liu H; Jiang P; Yu Z; Zhang Y
    Int J Health Plann Manage; 2011; 26(4):379-435. PubMed ID: 22213259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty years of health care economic analysis in Spain: are we doing well?
    García-Altés A
    Health Econ; 2001 Dec; 10(8):715-29. PubMed ID: 11747053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care technology in France.
    Weill C
    Health Policy; 1994; 30(1-3):123-62. PubMed ID: 10139489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of Economic Evaluation in Health Care: An Indian Perspective.
    Dang A; Likhar N; Alok U
    Value Health Reg Issues; 2016 May; 9():78-83. PubMed ID: 27881265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Theoretical implications of health economic evaluations in an Austrian context].
    Walter E; Zehetmayr S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):622-7. PubMed ID: 17211767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.